1881 related articles for article (PubMed ID: 23267834)
1. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
Ki SH; Cho IJ; Choi DW; Kim SG
Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
5. Regulation of energy metabolism by long-chain fatty acids.
Nakamura MT; Yudell BE; Loor JJ
Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
[TBL] [Abstract][Full Text] [Related]
6. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.
Martens C; Bilodeau S; Maira M; Gauthier Y; Drouin J
Mol Endocrinol; 2005 Apr; 19(4):885-97. PubMed ID: 15591535
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
8. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation.
Papi A; Contoli M; Adcock IM; Bellettato C; Padovani A; Casolari P; Stanciu LA; Barnes PJ; Johnston SL; Ito K; Caramori G
J Allergy Clin Immunol; 2013 Nov; 132(5):1075-1085.e6. PubMed ID: 23871663
[TBL] [Abstract][Full Text] [Related]
9. GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression.
Hua G; Paulen L; Chambon P
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E626-34. PubMed ID: 26712002
[TBL] [Abstract][Full Text] [Related]
10. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
11. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts.
Rogatsky I; Luecke HF; Leitman DC; Yamamoto KR
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16701-6. PubMed ID: 12481024
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of heat shock transcription factor by GR.
Wadekar SA; Li D; Periyasamy S; Sánchez ER
Mol Endocrinol; 2001 Aug; 15(8):1396-410. PubMed ID: 11463862
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII): implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism.
De Martino MU; Alesci S; Chrousos GP; Kino T
Ann N Y Acad Sci; 2004 Jun; 1024():72-85. PubMed ID: 15265774
[TBL] [Abstract][Full Text] [Related]
14. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
15. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.
Wu J; Li Y; Dietz J; Lala DS
Mol Endocrinol; 2004 Jan; 18(1):53-62. PubMed ID: 14551261
[TBL] [Abstract][Full Text] [Related]
16. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
17. A rapid interference between glucocorticoids and cAMP-activated signalling in hypothalamic neurones prevents binding of phosphorylated cAMP response element binding protein and glucocorticoid receptor at the CRE-Like and composite GRE sites of thyrotrophin-releasing hormone gene promoter.
Díaz-Gallardo MY; Cote-Vélez A; Charli JL; Joseph-Bravo P
J Neuroendocrinol; 2010 Apr; 22(4):282-93. PubMed ID: 20136691
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by insulin of glucocorticoid-induced gene transcription: involvement of the ligand-binding domain of the glucocorticoid receptor and independence from the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways.
Pierreux CE; Ursø B; De Meyts P; Rousseau GG; Lemaigre FP
Mol Endocrinol; 1998 Sep; 12(9):1343-54. PubMed ID: 9731703
[TBL] [Abstract][Full Text] [Related]
19. 3',5'-cyclic adenosine monophosphate response element-binding protein and CCAAT enhancer-binding protein are dispensable for insulin inhibition of phosphoenolpyruvate carboxykinase transcription and for its synergistic induction by protein kinase A and glucocorticoids.
Yeagley D; Quinn PG
Mol Endocrinol; 2005 Apr; 19(4):913-24. PubMed ID: 15604115
[TBL] [Abstract][Full Text] [Related]
20. Nuclear corepressor is required for inhibition of phosphoenolpyruvate carboxykinase expression by tumor necrosis factor-alpha.
Yan J; Gao Z; Yu G; He Q; Weng J; Ye J
Mol Endocrinol; 2007 Jul; 21(7):1630-41. PubMed ID: 17456789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
